Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R M Asquith

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Chemmedchem|May 3, 2020
Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline InhibitorsChristopher R M Asquith, Graham J Tizzard, James M Bennett, et al.
Scientific Reports|July 27, 2022
Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platformAndrew A Bieberich, Tuomo Laitinen, Kaitlyn Maffuid, et al.
Chemmedchem|August 12, 2016
Evaluation of Substituted 1,2,3-Dithiazoles as Inhibitors of the Feline Immunodeficiency Virus (FIV) Nucleocapsid Protein via a Proposed Zinc Ejection MechanismChristopher R M Asquith, Lidia S Konstantinova, Tuomo Laitinen, et al.
Bioorganic & Medicinal Chemistry|August 10, 2019
Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infectionChristopher R M Asquith, Bruno C Sil, Tuomo Laitinen, et al.
Chemmedchem|November 2, 2019
Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity RelationshipsChristopher R M Asquith, Tuomo Laitinen, James M Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2021
Design and evaluation of 1,2,3-dithiazoles and fused 1,2,4-dithiazines as anti-cancer agentsKaitlyn A Maffuid, Maria Koyioni, Chad D Torrice, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2015
Novel fused tetrathiocines as antivirals that target the nucleocapsid zinc finger containing protein of the feline immunodeficiency virus (FIV) as a model of HIV infectionChristopher R M Asquith, Marina L Meli, Lidia S Konstantinova, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2019
Quinazoline-Based Antivirulence Compounds Selectively Target <i>Salmonella</i> PhoP/PhoQ Signal Transduction SystemMaría Ayelén Carabajal, Christopher R M Asquith, Tuomo Laitinen, et al.
Scientific Reports|March 1, 2024
Enhancing colistin efficacy against Salmonella infections with a quinazoline-based dual therapeutic strategyCarlos A Lobertti, Fernán O Gizzi, Christian Magni, et al.
Antibiotics (Basel, Switzerland)|December 11, 2019
Synthesis and Identification of Pentathiepin-Based Inhibitors of <i>Sporothrix brasiliensis</i>Christopher R M Asquith, Ana C S Machado, Luisa H M de Miranda, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Chemmedchem|May 3, 2020
Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline InhibitorsChristopher R M Asquith, Graham J Tizzard, James M Bennett, et al.
Scientific Reports|July 27, 2022
Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platformAndrew A Bieberich, Tuomo Laitinen, Kaitlyn Maffuid, et al.
Chemmedchem|August 12, 2016
Evaluation of Substituted 1,2,3-Dithiazoles as Inhibitors of the Feline Immunodeficiency Virus (FIV) Nucleocapsid Protein via a Proposed Zinc Ejection MechanismChristopher R M Asquith, Lidia S Konstantinova, Tuomo Laitinen, et al.
Bioorganic & Medicinal Chemistry|August 10, 2019
Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infectionChristopher R M Asquith, Bruno C Sil, Tuomo Laitinen, et al.
Chemmedchem|November 2, 2019
Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity RelationshipsChristopher R M Asquith, Tuomo Laitinen, James M Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2021
Design and evaluation of 1,2,3-dithiazoles and fused 1,2,4-dithiazines as anti-cancer agentsKaitlyn A Maffuid, Maria Koyioni, Chad D Torrice, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2015
Novel fused tetrathiocines as antivirals that target the nucleocapsid zinc finger containing protein of the feline immunodeficiency virus (FIV) as a model of HIV infectionChristopher R M Asquith, Marina L Meli, Lidia S Konstantinova, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2019
Quinazoline-Based Antivirulence Compounds Selectively Target <i>Salmonella</i> PhoP/PhoQ Signal Transduction SystemMaría Ayelén Carabajal, Christopher R M Asquith, Tuomo Laitinen, et al.
Scientific Reports|March 1, 2024
Enhancing colistin efficacy against Salmonella infections with a quinazoline-based dual therapeutic strategyCarlos A Lobertti, Fernán O Gizzi, Christian Magni, et al.
Antibiotics (Basel, Switzerland)|December 11, 2019
Synthesis and Identification of Pentathiepin-Based Inhibitors of <i>Sporothrix brasiliensis</i>Christopher R M Asquith, Ana C S Machado, Luisa H M de Miranda, et al.
Pageof 6